In a Perturb-Seq screen of human GBM cells treated with radiotherapy, CYP19A1, which encodes aromatase (CYP19A1), was found to be among the most differentially expressed genes over normal conditions. The gene discussed is CYP19A1; the disease is glioblastoma.